Read by QxMD icon Read

Cancer Genomics & Proteomics

Jong Hyuk Yoon, Dayea Kim, Jaeyoon Kim, Hyeongjoo Lee, Jaewang Ghim, Byung Jun Kang, Parkyong Song, Pann-Ghill Suh, Sung Ho Ryu, Taehoon G Lee
BACKGROUND: There are limitations to current colorectal cancer (CRC)-specific diagnostic methods and therapies. Tumorigenesis proceeds because of interaction between cancer cells and various surrounding cells; discovering new molecular mediators through studies of the CRC secretome is a promising approach for the development of CRC diagnostics and therapies. MATERIALS AND METHODS: A comparative secretomic analysis was performed using primary and metastatic human isogenic CRC cells...
November 2018: Cancer Genomics & Proteomics
Kittirat Saharat, Kriengsak Lirdprapamongkol, Daranee Chokchaichamnankit, Chantragan Srisomsap, Jisnuson Svasti, N Monique Paricharttanakul
BACKGROUND/AIM: Resistance to anoikis is a pre-requisite step in metastasis, a major cause of death in patients with cancer, including thyroid cancer. Impairing anoikis resistance is a possible strategy for therapy of metastatic cancer. We, therefore, we aimed to investigate the key players of anoikis resistance. MATERIALS AND METHODS: Papillary-type (BCPAP), follicular-type (FTC133), and anaplastic-type (ARO) thyroid carcinoma cells, cultured in poly(2-hydroxyethyl methacrylate)-coated plates to mimic circulating cells, were used as model systems in this study...
November 2018: Cancer Genomics & Proteomics
Christos Christodoulou, Georgios Oikonomopoulos, Georgia Angeliki Koliou, Ioannis Kostopoulos, Vassiliki Kotoula, Mattheos Bobos, George Pentheroudakis, George Lazaridis, Maria Skondra, Sofia Chrisafi, Angelos Koutras, Dimitrios Bafaloukos, Evangelia Razis, Kyriaki Papadopoulou, Pavlos Papakostas, Haralambos P Kalofonos, Dimitrios Pectasides, Pantelis Skarlos, Konstantine T Kalogeras, George Fountzilas
BACKGROUND: Trastuzumab is a monoclonal antibody against HER2-positive breast cancer. Despite improving the natural history of the disease, there is a number of patients who are resistant to it, whereas all patients will eventually develop resistance and disease will progress. Inconsistent preclinical data show that the IGF-R pathway may contribute to either de novo or acquired resistance to trastuzumab. MATERIALS AND METHODS: In total, 227 trastuzumab-treated metastatic breast cancer patients were evaluated for IGF-1, IGF-1R, GLP-1R, Akt1, Akt2 Akt3 mRNA expression, and IGF-1Rα, IGF-1Rβ, IGF-2R protein expression...
November 2018: Cancer Genomics & Proteomics
Chun-Ming Yen, Chia-Wen Tsai, Wen-Shin Chang, Yi-Chin Yang, Yi-Wen Hung, Hsu-Tung Lee, Chiung-Chyi Shen, Meei-Ling Sheu, Ju-Yu Wang, Chi-Li Gong, Wen-Yu Cheng, DA-Tian Bau
AIM: Arsenic trioxide (As2 O3 ), known as pi-shuang and the most toxic compound in traditional Chinese medicine, has been used as an antitumor agent for thousands of years. Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a natural phenol that has significant anti-bacterial, anti-fungaI and antiaging activities. Our study aimed to examine the combined anticancer effects of As2 O3 and resveratrol against human neuroblastoma SK-N-SH cells, and elucidate the underlying intracellular signaling...
November 2018: Cancer Genomics & Proteomics
Ritika Gera, Leon Mokbel, Wen G Jiang, Kefah Mokbel
BACKGROUND: Cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) interacts with CDK2AP2, modulates the actions of transforming growth factor-B1, cyclin-dependent kinase 2 and retinoblastoma protein, and closely interacts with micro-RNA21 and micro-RNA25. Our objective was to determine if CDK2AP1 mRNA expression levels were consistent with tumour-suppressive functions in breast cancer. MATERIALS AND METHODS: A total of 134 samples were analysed. CDK2AP1 mRNA levels were measured using quantitative polymerase chain reaction (RT-PCR) and normalised against glyceraldehyde 3-phosphate dehydrogenase mRNA...
November 2018: Cancer Genomics & Proteomics
Lene E Johannessen, Petter Brandal, Tor Åge Myklebust, Sverre Heim, Francesca Micci, Ioannis Panagopoulos
BACKGROUND: Although methylation of the O6 -methylguanine-DNA methyltransferase (MGMT) gene promoter predicts response to temozolomide in patients with glioblastoma, no consensus exists as to which assay is best for its detection. MATERIALS AND METHODS: Methylation of MGMT promoter was examined by methylation-specific polymerase chain reaction (MSP), quantitative real-time MSP, methylation-sensitive high-resolution melting analysis, and two commercial pyrosequencing (PSQ) kits...
November 2018: Cancer Genomics & Proteomics
Ourania Romanidou, Vassiliki Kotoula, George Fountzilas
Isocitrate dehydrogenases 1 and 2 (IDH1/2) are enzymes that play a major role in the Krebs cycle. Mutations in these enzymes are found in the majority of lower gliomas and secondary glioblastomas, but also in myeloid malignancies and other cancers. IDH1 and IDH2 mutations are restricted to specific arginine residues in the active site of the enzymes and are gain-of-function, i.e. they confer a neomorphic enzyme activity resulting in the accumulation of D-2-hydroxyglutarate (2-HG). 2-HG is an oncometabolite causing profound metabolic dysregulation which, among others, results in methylator phenotypes and in defects in homologous recombination repair...
September 2018: Cancer Genomics & Proteomics
Norihisa Saeki, Akira Saito, Yuki Sugaya, Mitsuhiro Amemiya, Hiroki Sasaki
BACKGROUND/AIM: Overall survival for the high-risk group of neuroblastoma (NB) patients still remains at 40-50%, necessitating the establishment of a curable treatment. LIM domain only 1 (LMO1) gene encoding a transcriptional regulator is an NB-susceptibility gene with a tumor-promoting activity. Previously we conducted chromatin immunoprecipitation and DNA sequencing analyses on NB cell lines and identified 3 protein-coding genes regulated by LMO1. In this study, we extended our analyses to capture microRNA genes directly or indirectly regulated by LMO1...
September 2018: Cancer Genomics & Proteomics
Te-Cheng Yueh, Yi-Wen Hung, Tzu-Ching Shih, Cheng-Nan Wu, Shou-Cheng Wang, Yi-Liang Lai, Shih-Wei Hsu, Ming-Hsien Wu, Chun-Kai Fu, Yun-Chi Wang, Tao-Wei Ke, Wen-Shin Chang, Chia-Wen Tsai, DA-Tian Bau
BACKGROUND/AIM: The genomic role of human mouse double minute 2 (MDM2) in colorectal cancer (CRC) is unclear, therefore, our study aimed to evaluate the contribution of MDM2 genotype to the risk of CRC in Taiwan. MATERIALS AND METHODS: In this case-control study, MDM2 SNP309 T to G (rs2279744) genotypes were determined and their association with CRC risk were investigated among 362 patients with CRC and 362 age- and gender-matched healthy controls in central Taiwan...
September 2018: Cancer Genomics & Proteomics
Josef Maryáš, Jakub Faktor, Lenka Čápková, Petr Müller, Petr Skládal, Pavel Bouchal
BACKGROUND/AIM: Pul-down assay is a popular in vitro method for identification of physical interactors of selected proteins. Here, for the first time, we compared three conventional variants of pull-down assay with the streptavidin-modified surface plasmon resonance (SPR) chips for the detection of PDZ and LIM domain protein 2 (PDLIM2) interaction partners. MATERIALS AND METHODS: PDLIM2 protein-protein interactions were analysed by three variants of pull-down assay on streptavidin beads using LC-MS/MS in "Sequential Window Acquisition of all Theoretical fragment ion spectra (SWATH)" mode and compared with LC-SWATH-MS/MS data from SPR chips...
September 2018: Cancer Genomics & Proteomics
Steven Lehrer, Peter H Rheinstein
BACKGROUND: One aspect of smoking and lung cancer that has not been closely examined, is that regarding genes that may predispose to tobacco dependence. Smoking and mental illness are tightly linked, apparently the result of smokers using cigarettes to self-medicate for mental problems. The gene for solute carrier family 18 member A1 (vesicular monoamine transporter; SLC18A1) is of particular interest in this regard because of its association with schizophrenia, autism and bipolar illness as well as with cancer...
September 2018: Cancer Genomics & Proteomics
Ioannis Panagopoulos, Ludmila Gorunova, Henning Leske, Pitt Niehusmann, Lene E Johannessen, Julie Staurseth, Nina Øino, Torstein R Meling, Sverre Heim, Francesca Micci, Petter Brandal
BACKGROUND: Methylation of the O6 -methylguanine-DNA methyltransferase (MGMT) gene promoter is a well-established predictor of response to the DNA-alkylating agent temozolomide in patients with glioblastoma. MATERIALS AND METHODS: Pyrosequencing analysis was used to determine the MGMT promoter methylation status in 61 meningiomas, to clarify whether it might have a predictive role. RESULTS: Only two tumors (3%) had a mean methylation frequency higher than the cut-off value of 10% for the four CpG sites examined...
September 2018: Cancer Genomics & Proteomics
Ha Vu Tran, Alexandra K Kiemer, Volkhard Helms
BACKGROUND/AIM: Genomic DNA copy number alterations (CNAs) are frequent in tumors and have been catalogued by The Cancer Genome Atlas project. Emergence of chemoresistance frequently renders drug therapies ineffective. MATERIALS AND METHODS: We analyzed how CNAs recurrently found in the genomes of TCGA patients of thirty-one tumor types affect protein targets of antineoplastic (AN) agents. RESULTS: CNA deletions more frequently affected the targets of AN agents than CNA amplifications...
September 2018: Cancer Genomics & Proteomics
Elizabeth A Mazzio, Karam F A Soliman
BACKGROUND: Malignant melanoma cells can rapidly acquire phenotypic properties making them resistant to radiation and mainline chemotherapies such as decarbonize or kinase inhibitors that target RAS-proto-oncogene independent auto-activated mitogen-activated protein kinases (MAPK)/through dual specificity mitogen-activated protein kinase (MEK). Both drug resistance and inherent transition from melanocytic nevi to malignant melanoma involve the overexpression of histone deacetylases (HDACs) and a B-Raf proto-oncogene (BRAF) mutation...
September 2018: Cancer Genomics & Proteomics
Akihide Kondo, Yuzaburo Shimizu, Satoshi Adachi, Ikuko Ogino, Mario Suzuki, Osamu Akiyama, Hajime Arai
BACKGROUND: Fusion genes driving tumourigenesis have drawn the attention of researchers and oncologists. Despite the importance of such molecular alterations, there are no comprehensive reproducible methods for detecting fusion genes. MATERIALS AND METHODS: Nineteen paediatric brain tumours of five types, namely pilocytic astrocytoma, oligodendroglioma, anaplastic astrocytoma, glioblastoma and, ganglioglioma, were examined to detect fusion genes using a pyrosequencing-based method following RNA isolation, cDNA synthesis and real-time polymerase chain reaction...
July 2018: Cancer Genomics & Proteomics
Yoon Hee Lee, Min Kyung Kim, Hee Young Moon, Gun Oh Chong, Hyun Jung Lee, Yoon Soon Lee, Ji Young Park, Chan Hyeong Lee, Moon Chang Baek, Dae Gy Hong
BACKGROUND/AIM: This study was designed to identify candidate proteins which can be used for visualization of pelvic autonomic nerve during nerve-sparing surgery. MATERIALS AND METHODS: Both soft tissue and vesical branch of the inferior hypogastric nerve from five women were collected during surgery. These 10 tissue specimens were analysed using liquid chromatography-mass spectrometry (LC-MS) and Human Protein Atlas (HPA) for protein expression. The existence of nerve fibres was confirmed using haematoxylin and eosin (H&E) and anti-S-100 staining...
July 2018: Cancer Genomics & Proteomics
Elżbieta Fiedor, Karolina Zajda, Ewa L Gregoraszczuk
BACKGROUND/AIM: A common finding in cancer cells is the overexpression of histone deacetylases (HDACs), leading to altered expression and activity of numerous proteins involved in carcinogenesis. Considering that leptin can modulate the levels of HDACs, we hypothesised that leptin receptor antagonists can alter HDAC expression. MATERIALS AND METHODS: HDAC expression in cells exposed to leptin and leptin receptor antagonists (SHLA and Lan2) were evaluated in ovarian epithelial (OVCAR-3, CaOV3) and folliculoma (COV434, KGN) cells...
July 2018: Cancer Genomics & Proteomics
Petr Karasek, Natalia Gablo, Jan Hlavsa, Igor Kiss, Petra Vychytilova-Faltejskova, Marketa Hermanova, Zdenek Kala, Ondrej Slaby, Vladimir Prochazka
Blood plasma microRNAs (miRNAs) are emerging as a clinically useful tool for non-invasive detection and prognosis estimation in various cancer types including pancreatic ductal adenocarcinoma (PDAC). The aim of the present study was to provide an independent validation of circulating miRNAs identified in previous studies as diagnostic and/or prognostic biomarkers in PDAC. Based on the literature search, 6 miRNAs were chosen as candidates for independent validation; miR-21-5p, miR-375, miR-155, miR-17-5p, miR-126-5p and miR-1290...
July 2018: Cancer Genomics & Proteomics
Dai Shimizu, Tomoko Saito, Shuhei Ito, Takaaki Masuda, Junji Kurashige, Yosuke Kuroda, Hidetoshi Eguchi, Yasuhiro Kodera, Koshi Mimori
BACKGROUND: Peritoneal dissemination (PD) is one of the most common causes of cancer-related mortality in gastric cancer (GC). We aimed to identify PD-associated genes and investigate their role in GC. MATERIALS AND METHODS: We identified FGFR1 as a putative PD-associated gene using a bioinformatics approach. The biological significance of FGFR1 in epithelial-to-mesenchymal transition (EMT) was evaluated according to the correlation with genes that participated in EMT and FGFR1 knockdown experiments...
July 2018: Cancer Genomics & Proteomics
Mario Menschikowski, Carsten Jandeck, Markus Friedemann, Susan Richter, Dana Thiem, Björn Sönke Lange, Meinolf Suttorp
BACKGROUND/AIM: DNA methylation plays an important role in the initiation and propagation of carcinogenesis; however, the role of heterogeneously methylated epialleles is currently not well studied, also due to the lack of sensitive, unbiased and high throughput methods. Here, a newly developed droplet digital PCR (ddPCR)-based method was evaluated regarding its ability to quantify such heterogeneously methylated epialleles with sufficient analytical sensitivity and specificity. MATERIALS AND METHODS: Genomic DNA from blood leukocytes and bone marrow aspirate of an 8-year old male with B-cell acute lymphoblastic leukemia (B-ALL) and from normal and malignant prostate cell lines were analysed using ddPCR...
July 2018: Cancer Genomics & Proteomics
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"